Truong Vu 4/A
4/A · Aridis Pharmaceuticals, Inc. · Filed Aug 29, 2019
Insider Transaction Report
Form 4/AAmended
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
- Award
Stock Options
2019-02-20+200,000→ 496,050 totalExercise: $8.20Exp: 2029-02-20→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The Stock Options vest in equal installments over 48 months, beginning on March 20, 2019.
- [F2]The original form 4 reported the exercise price as $8.46. The original form 4 also reported the number of derivative securities beneficially owned following the reported transaction as 316,861.